Abhi Jain

Research

Most of my work asks one question of different parts of the same system: what can a brain image measure that the eye can’t, and does it change what happens to the patient?

Sixteen peer-reviewed papers, fifteen abstracts, and five educational exhibits. The full list is in the CV.

Memory and the aging hippocampus

LATE, limbic-predominant age-related TDP-43 encephalopathy, is common in the oldest brains and easy to mistake for Alzheimer’s disease during life. With collaborators, I’m asking whether the texture of hippocampal subfields on MRI can tell the two apart, starting with postmortem scans where the pathology is known. The interest is older than my radiology career: my first publication, in 2016, modeled inflammation relevant to Alzheimer’s disease in cultured immune cells.

  • Funded by the Foundation of the American Society of Neuroradiology to study radiomics of hippocampal subfields in LATE.

    2025. Principal Co-Investigator
  • First results on hippocampal subfield radiomics in LATE, followed by a postmortem MRI signature of LATE neuropathological change presented as an oral talk.

    Alzheimer’s & Dementia, 2025. Alzheimer’s Imaging Consortium, AAIC, July 2026
  • In the clinic, the same questions come up at Stanford’s Multidisciplinary Memory Conference, and in teaching: talks on imaging and radiomics of the hippocampus at USC and for Stanford’s neuroradiology fellows.

    2024 to now

Hemorrhage and stroke on CT

Hematoma volume has long been the default predictor after intracerebral hemorrhage. Working with the ATACH-2 trial dataset, our group showed that the shape and texture of a bleed carry signal its size doesn’t.

Aneurysms and flow diversion

During medical school I worked with neurosurgical and neurointerventional teams on how flow-diverting stents heal aneurysms, how to follow them, and how to keep patients safe on antiplatelet therapy.

  • Across 259 aneurysms treated with the Pipeline device, occlusion accumulated from about 38% at six months to 78% at a year and 85% at two years. That curve became a proposed follow-up imaging schedule.

    Journal of Neurosurgery, 2018
  • About one in four aneurysms stayed incompletely occluded. Age over 70, size of 15 mm or more, and fusiform shape predicted it.

    Journal of Neurosurgery, 2019
  • Two flow diverters, Pipeline and FRED, performed comparably in matched internal carotid aneurysms, with 80% complete occlusion for each.

    Neurosurgery, 2019
  • On antiplatelet therapy: a pharmacy-managed protocol compared with one-time platelet testing before Pipeline placement, and a review arguing for genotype- and response-guided P2Y12 therapy.

    Neurosurgery, 2019. Interventional Neuroradiology, 2021

AI in the reading room

The throughline since residency: tools that give radiologists time back and measurements they can’t make by hand, judged in real workflows rather than on benchmarks alone.

  • Language models that draft the impression of a radiology report, and a funded project on automated report generation. Then the human side: whether natural language tools speed dictation and ease burnout.

    RSNA, 2021. Einstein Healthcare Network, 2022 to 2023, Co-Investigator. SIIM, 2023
  • Opportunistic screening: an AI model that finds coronary artery calcium on chest CTs ordered for other reasons.

    SIIM, 2023
  • A review of AI in brain tumor imaging concluding that the promise is real, but multicenter validation and standardized image pipelines have to come first.

    Seminars in Ultrasound, CT and MR, 2022
  • Tailored language models for personalized radiology education, as an invited RSNA talk. For carotid plaque, a synthesis for WNRS: what AI adds is reach, consistency, and measurements no one can make by eye.

    RSNA, Chicago, 2024. Western Neuroradiological Society, 2026: slides and takeaways
  • Now at Stanford: informatics work on how neuroradiology studies are hung and read, and on evaluating AI tools before clinical use. Nationally, the ASNR AI Committee and its white paper.

    2025 to now

Rehabilitation

Before medicine I was a physical therapist, and some of the first questions I studied were about getting people back what a stroke or injury took.

  • Telerehabilitation after stroke: across 34 studies and 1,025 patients, every study reported improvement from baseline, though the methodological quality of the evidence was modest.

    Telemedicine and e-Health, 2021. First presented at the American Society of Neurorehabilitation, 2018
  • A review of neuroprotective strategies in traumatic brain injury, and why so many have failed a heterogeneous disease.

    Journal of Neurosurgical Sciences, 2018

Where it’s heading

Three threads I’m pulling on now. The aging brain: imaging biomarkers that separate neurodegenerative diseases while they can still be changed. The carotid as a place for prevention: plaque and vessel wall imaging that finds risk before a stroke, not after. And AI that makes both measurable at scale, from foundation models trained on a health system’s own images to tools that fit the reading room. Underneath all three is one question: what it would take to keep a brain healthy across a whole lifetime.

If you’re working on any of this, write to me.